In this monograph, expert faculty review the challenges and limitations of the current methods of retinal disease management, detail the mechanisms by which TKIs affect retinal disease progression, report the latest clinical evidence on emerging TKIs for patients with nAMD and DR, and discuss the role and impact of TKIs on existing treatment paradigms.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 6900 Grove Road
Pricing
100% of listed courses are free
259 of 259 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Rhinology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Article / monograph / reference
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 31, 2025
-
Last day to claim creditOct 31, 2026 3 weeks left
-
Paradigm Medical Communications, LLC Innovations in Sustained Treatment of nAMD: An Update on TKI Therapies From ARVO 2026
-
Impact Education +1 Advanced Clinical Updates in Retinal Diseases for Managed Care Professionals
-
PRIME Education, Inc. (PRIME®) Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease
-
Vindico Medical Education, LLC TKIs in Retinal Disease: Unlocking Their Full Potential
-
Vindico Medical Education, LLC The Retina Radar With Dr. Arshad Khanani on New Mechanisms, TKIs, and Macular Telangiectasia
-
Vindico Medical Education, LLC Advancing Exudative Retinal Disease Management Through Tyrosine Kinase Inhibition
